Predicting Pathological Nodal Status after Neoadjuvant Immunochemotherapy in NSCLC Using Dual-Region Longitudinal CT
Research question
Among patients with non-small cell lung cancer (NSCLC) who received neoadjuvant immunochemotherapy followed by curative surgery, investigate the predictive value of primary-tumor and lymph-node features from pre- and post-treatment chest CT for patient-level postoperative pathological nodal status (ypN).
Work to date
- Audit image–mask geometry, feature extraction, and cohort manifests to trace information loss in preprocessing and local representations.
- Use fixed patient-level splits, training-only fitting, and leave-one-center-out (LOCO) validation to compare features and models and examine dependence on center differences.
- Compare Logistic baselines, single-factor fixes, and candidates including TabPFN; assess paired uncertainty, calibration, and cross-center stability before retaining changes.
Current stage
The study is ongoing, focusing on reliable baselines, identifying information loss, and improving representations. Current candidates do not yet support stable adoption; no final model has been selected.